1.
M Boccadoro, C Tarella, A Palumbo, C Argentino, S Triolo, A Dominietto, V Callea, VM Lauta, S Molica, P Musto, F Marmont, AM Gianni, A Pileri. An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. haematol [Internet]. 1999Jan.1 [cited 2024Feb.29];84(10):905-10. Available from: https://haematologica.org/article/view/1497